If approval got announced tomorrow and NWBO manages to not absolutely botch the PR, it's 100% best case. $0.50.
If NWBO botches the PR, which is highly likely, we're looking at like 40 million shares volume and up 12%.
"Northwest Bio is pleased to announced that the MHRA has approved it's application for a marketing license for DCVax-L. This is the product of decades of work. We plan to do more work on this in the future. More about NWBO: ........"